Simplex Trading’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
Other funds holding LYEL
OP
Simplex Trading's LYEL Position: Q3 2026 in Review
Simplex Trading increased its Lyell Immunopharma (LYEL) stake by 512% in Q3 2026, buying an estimated $15.4K and bringing the position to 1,383 shares worth $13.5K. The position accounts for ﹤0.01% of the portfolio, ranked #7372.
Simplex Trading first reported a position in LYEL in Q4 2021 and has held it in 15 quarters since. The position peaked at $22K in Q2 2022. 105 funds tracked by Wall St. Rank hold LYEL as of Q3 2026.
- Simplex Trading held 1,383 shares of Lyell Immunopharma worth $13.5K as of Q3 2026.
- Simplex Trading bought 1,157 Lyell Immunopharma shares in Q3 2026, an estimated $15.4K.
- Lyell Immunopharma made up ﹤0.01% of Simplex Trading's portfolio in Q3 2026, its #7372 holding.
- Simplex Trading first reported a position in Lyell Immunopharma in Q4 2021 and has held it in 15 quarters since.
- Simplex Trading's Lyell Immunopharma position peaked at $22K in Q2 2022.
- 105 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q3 2026.
Based on Simplex Trading's 13F filing for Q3 2026, filed 4 Nov 2026.